Graeme Murray

857 total citations
29 papers, 611 citations indexed

About

Graeme Murray is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Graeme Murray has authored 29 papers receiving a total of 611 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 12 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in Graeme Murray's work include Acute Myeloid Leukemia Research (13 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Histone Deacetylase Inhibitors Research (5 papers). Graeme Murray is often cited by papers focused on Acute Myeloid Leukemia Research (13 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Histone Deacetylase Inhibitors Research (5 papers). Graeme Murray collaborates with scholars based in United States, Jordan and Canada. Graeme Murray's co-authors include Jason Reed, Tareq Saleh, Hisashi Harada, David A. Gewirtz, John F. Zimmerman, Bozhi Tian, Moureq R. Alotaibi, Liliya Tyutyunyk‐Massey, Yucai Wang and Andrew J. Souers and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Graeme Murray

26 papers receiving 602 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Graeme Murray United States 11 242 188 176 139 92 29 611
Lijuan He United States 18 485 2.0× 119 0.6× 213 1.2× 150 1.1× 35 0.4× 36 995
Weiyang Jin China 12 320 1.3× 86 0.5× 149 0.8× 219 1.6× 318 3.5× 19 922
Anabel‐Lise Le Roux Spain 11 689 2.8× 172 0.9× 263 1.5× 93 0.7× 53 0.6× 15 1.4k
Sreeja B. Asokan United States 13 368 1.5× 55 0.3× 243 1.4× 154 1.1× 112 1.2× 18 1.1k
Bidisha Sinha India 8 586 2.4× 250 1.3× 353 2.0× 109 0.8× 39 0.4× 20 1.3k
Lisa Sharek United States 10 530 2.2× 77 0.4× 91 0.5× 141 1.0× 66 0.7× 11 865
Richard Ruez France 5 512 2.1× 198 1.1× 77 0.4× 47 0.3× 88 1.0× 8 862
Volker Andresen Germany 12 276 1.1× 72 0.4× 275 1.6× 258 1.9× 60 0.7× 20 861
Zhengpeng Wan United States 20 430 1.8× 99 0.5× 449 2.6× 244 1.8× 349 3.8× 42 1.3k

Countries citing papers authored by Graeme Murray

Since Specialization
Citations

This map shows the geographic impact of Graeme Murray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Graeme Murray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Graeme Murray more than expected).

Fields of papers citing papers by Graeme Murray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Graeme Murray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Graeme Murray. The network helps show where Graeme Murray may publish in the future.

Co-authorship network of co-authors of Graeme Murray

This figure shows the co-authorship network connecting the top 25 collaborators of Graeme Murray. A scholar is included among the top collaborators of Graeme Murray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Graeme Murray. Graeme Murray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murray, Graeme, et al.. (2024). Venetoclax with decitabine or azacitidine in relapsed or refractory acute myeloid leukemia. Medical Oncology. 41(3). 80–80. 7 indexed citations
2.
Murray, Graeme, et al.. (2024). Clonal Evolution in 207 Cases of Refractory or Relapsed Acute Myeloid Leukemia. European Journal Of Haematology. 114(1). 98–104.
3.
4.
Murray, Graeme, et al.. (2023). The Impact of Delayed Venetoclax Initiation on Overall Survival in Acute Myeloid Leukemia. Blood. 142(Supplement 1). 4233–4233. 1 indexed citations
5.
Murray, Graeme, et al.. (2023). Venetoclax with decitabine or azacitidine in the first‐line treatment of acute myeloid leukemia. SHILAP Revista de lepidopterología. 4(2). 381–392. 14 indexed citations
6.
Murray, Graeme, et al.. (2023). The impact of secondary-type mutations in newly diagnosed acute myeloid leukemia treated with venetoclax and decitabine or azacitidine.. Journal of Clinical Oncology. 41(16_suppl). e19048–e19048. 1 indexed citations
7.
Murray, Graeme, et al.. (2023). Clinical outcomes of core binding factor acute myeloid leukemia in the modern era.. Journal of Clinical Oncology. 41(16_suppl). e19054–e19054. 1 indexed citations
8.
9.
Murray, Graeme, et al.. (2023). Treatment phase stratified outcomes of core binding factor acute myeloid leukemia.. Journal of Clinical Oncology. 41(16_suppl). e19055–e19055. 1 indexed citations
10.
Murray, Graeme, et al.. (2023). IDH inhibitors or chemotherapy in relapsed or refractory IDHmut acute myeloid leukemia.. Journal of Clinical Oncology. 41(16_suppl). e19043–e19043. 1 indexed citations
11.
Tebon, Peyton, Ardalan Davarifar, Brandon L. Tsai, et al.. (2023). Drug screening at single-organoid resolution via bioprinting and interferometry. Nature Communications. 14(1). 3168–3168. 82 indexed citations
12.
Murray, Graeme, et al.. (2023). The Molecular Landscape of Acute Myeloid Leukemia with Trisomy 8: A Comprehensive Cancer Center Analysis of 627 Patients. Blood. 142(Supplement 1). 6053–6053. 1 indexed citations
13.
Murray, Graeme, et al.. (2021). Identification of nuclear export inhibitor-based combination therapies in preclinical models of triple-negative breast cancer. Translational Oncology. 14(12). 101235–101235. 11 indexed citations
14.
Carpenter, Valerie J., Tareq Saleh, So Min Lee, et al.. (2021). Androgen-deprivation induced senescence in prostate cancer cells is permissive for the development of castration-resistance but susceptible to senolytic therapy. Biochemical Pharmacology. 193. 114765–114765. 36 indexed citations
15.
Saleh, Tareq, Liliya Tyutyunyk‐Massey, Graeme Murray, et al.. (2018). Tumor cell escape from therapy-induced senescence. Biochemical Pharmacology. 162. 202–212. 128 indexed citations
16.
Meng, Fanchi, Graeme Murray, Lukasz Kurgan, & Henry J. Donahue. (2018). Functional and structural characterization of osteocytic MLO-Y4 cell proteins encoded by genes differentially expressed in response to mechanical signals in vitro. Scientific Reports. 8(1). 6716–6716. 11 indexed citations
17.
18.
Zimmerman, John F., Ramya Parameswaran, Graeme Murray, et al.. (2016). Cellular uptake and dynamics of unlabeled freestanding silicon nanowires. Science Advances. 2(12). e1601039–e1601039. 81 indexed citations
19.
Zimmerman, John F., Graeme Murray, Yucai Wang, et al.. (2015). Free-Standing Kinked Silicon Nanowires for Probing Inter- and Intracellular Force Dynamics. Nano Letters. 15(8). 5492–5498. 37 indexed citations
20.
Murray, Graeme, et al.. (1995). Reuse of disposable laparoscopic instruments: a study of related surgical complications.. PubMed. 38(6). 497–500. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lijuan He Breakdown of academic impact, for papers by Weiyang Jin Breakdown of academic impact, for papers by Anabel‐Lise Le Roux Breakdown of academic impact, for papers by Sreeja B. Asokan Breakdown of academic impact, for papers by Bidisha Sinha Breakdown of academic impact, for papers by Lisa Sharek Breakdown of academic impact, for papers by Richard Ruez Breakdown of academic impact, for papers by Volker Andresen Breakdown of academic impact, for papers by Zhengpeng Wan
Rankless by CCL
2026